Thin endometrial stripe does not affect pregnancy outcome in clomiphene citrate/intrauterine insemination cycles

2013 ◽  
Vol 100 (3) ◽  
pp. S77-S78
Author(s):  
A. Asante ◽  
Z. Khan ◽  
L.A. Schenck ◽  
J.R. Jensen ◽  
C.C. Coddington ◽  
...  
2006 ◽  
Vol 12 (4) ◽  
pp. 423-427 ◽  
Author(s):  
Amiram Magendzo ◽  
Juan-Enrique Schwarze ◽  
Claudia Diaz de la Vega ◽  
Elena Altieri ◽  
Fernando Zegers-Hochschild ◽  
...  

2004 ◽  
Vol 3 (3) ◽  
pp. 153-157
Author(s):  
MAMIKO WADA ◽  
TSUYOSHI KASAI ◽  
SEIICHIRO NAGAI ◽  
MICHIKO FUJIE ◽  
MAKI MIYAKE ◽  
...  

1997 ◽  
Vol 68 ◽  
pp. S201-S202
Author(s):  
G.L Kroll ◽  
D.E Moore ◽  
E.M Moore ◽  
N.A Klein ◽  
M.R Soules ◽  
...  

Author(s):  
Stephanie Rothenberg ◽  
Joseph Sanfilippo

The treatment of unexplained infertility has traditionally been comprised of a stepwise treatment approach, first with ovulation induction combined with intrauterine insemination (IUI) and then with in vitro fertilization (IVF). Ovulation induction is first attempted with clomiphene citrate, and, if unsuccessful, injectable gonadotropins are used. The value of ovulation induction with injectable gonadotropins in couples with unexplained infertility has been questioned, however, given the high risk of multiple gestation and the increasing efficacy of IVF. To address this, the FASTT trial randomized couples with unexplained infertility to a treatment arm that either included or omitted gonadotropin/IUI. They found that an accelerated treatment approach that involved 3 cycles of clomiphene citrate/IUI and then progressed immediately to IVF resulted in a decreased time to pregnancy compared to the group who underwent gonadotropin/IUI for 3 cycles, as well as decreased cost per live birth. Therefore, it was concluded that treatment of couples with unexplained infertility with gonadotropin/IUI was of no additional benefit.


Sign in / Sign up

Export Citation Format

Share Document